Compugen reported $129.41M in Current Assets for its fiscal quarter ending in June of 2026.





Current Assets Change Date
Arca Biopharma USD 941.49M 56.93M Sep/2026
aTyr Pharma USD 50.16M 8.21M Sep/2026
Bio Path USD 677K 14K Mar/2026
Brainstorm Cell Therapeutics USD 316K 132K Jun/2026
Cara Therapeutics USD 23.13M 2.2M Sep/2026
Clal Biotechnology ILS 14.69M 1.95M Dec/2023
Compugen USD 129.41M 7.88M Jun/2026
Immunic USD 135.09M 22.75M Sep/2026
Minerva Neurosciences USD 83.1M 70.08M Dec/2025
RedHill Biopharma USD 8.57M 2.05M Jun/2026
TherapeuticsMD USD 11.82M 303K Jun/2024